Search

everythinglearnresearchcommunity

for

Search:↓

New mutations in the SLC39A4 gene found in twins help understand the genetic cause of acrodermatitis enteropathica.

Disrupting Acvr1b in mice causes severe hair loss and thicker skin.

LMWP-PDGFA shows promise for improving hair health and treating hair loss with fewer side effects.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Down Syndrome patients with Alopecia Areata often have hypothyroidism and specific immune abnormalities.

A man with X-ALD improved after treatment, highlighting the need to consider X-ALD in similar patients and test their relatives.

Certain genetic variations are linked to hair loss in Mexican men.

Men with severe androgenetic alopecia, especially on the top of the head, have a higher risk of coronary artery disease.

Accurate diagnosis and understanding of alopecia areata in children are crucial for proper treatment.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

LHTric-1 is a specific antibody useful for studying hair and nail formation.

Higher inflammation markers are linked to more severe alopecia areata.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

Alzheimer's patients have higher levels of certain chemicals in their hair.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

Higher Galectin-3 levels are linked to insulin resistance and may predict androgenetic alopecia severity.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

Simvastatin reduces inflammation and promotes hair regrowth in alopecia areata.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Genomic approach finds new possible treatments for hair loss.

Baricitinib is a promising treatment for alopecia areata.

Higher levels of miR-203 may contribute to hair loss in alopecia areata.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

The summit concluded that new treatments like Jak inhibitors show promise for Alopecia Areata and personalized approaches are needed.

Genetic variation in the androgen receptor gene mainly causes early-onset hair loss, with maternal inheritance playing a key role.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.